Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Moderate hypofractionation for prostate cancer: A user's guide.

David I Pryor1,2, Sandra L Turner3,4, Keen Hun Tai5,6

  • 1Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Journal of Medical Imaging and Radiation Oncology
|January 17, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atomistic simulations of per- and polyfluoroalkyl substances self-assembly in water and insertion into the <i>E. coli</i> outer membrane.

Physical chemistry chemical physics : PCCP·2026
Same author

MAG-EX study protocol: magnetic stent versus stent on extraction string in patients after ureteroscopy-a multi-centre randomised controlled trial.

Translational andrology and urology·2026
Same author

Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum.

The Journal of urology·2026
Same author

Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial Substudy.

European urology oncology·2026
Same author

Ten Year Update on the Online and Social Media Presence of Australian and New Zealand Urologists.

ANZ journal of surgery·2026
Same author

Periprostatic Nerve Block During Transperineal Prostate Biopsy Under General Anaesthesia: Protocol for a Multicentre Pilot Randomised Controlled Trial.

Cancers·2026

Moderate hypofractionation is non-inferior to conventional fractionation for localized prostate cancer, showing similar disease control and toxicity. Patient selection and technique optimization are key for future moderately hypofractionated radiation therapy.

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Recent large randomized controlled trials (RCTs) and phase 2 studies have evaluated moderate hypofractionation for localized prostate cancer.
  • Mature follow-up data are now available, providing insights into long-term outcomes.

Purpose of the Study:

  • To review the evidence supporting moderate hypofractionation for localized prostate cancer.
  • To discuss patient selection criteria and implementation strategies for moderately hypofractionated radiation therapy.

Main Methods:

  • Analysis of data from three large RCTs published within the last year.
  • Review of mature follow-up data from phase 2 studies.

Main Results:

  • Moderate hypofractionation demonstrated non-inferiority to conventional fractionation regarding disease control and late toxicity at 5 years.
Keywords:
hypofractionationprostate cancerradiation therapy

Related Experiment Videos

  • No clinically significant differences in patient-reported outcomes were observed.
  • Phase 2 studies confirm low rates of significant toxicity at 10 years with moderate hypofractionation.

    • Conclusions:

    • Moderate hypofractionation is a safe and effective treatment option for localized prostate cancer.
    • Future treatment decisions will likely emphasize patient selection, androgen deprivation integration, and technique optimization over minor dose-fractionation variations.
    • Guidelines for implementing moderately hypofractionated radiation therapy in clinical practice are needed.